Sovaldi-velpatasir

Gilead gets FDA priority review of Hepatitis C combo drug
Marketwatch
Tue, 01/5/16 - 09:06 am
Gilead Sciences
FDA
priority review
hepatitis C
Sovaldi-velpatasir